Tag Archives: NASDAQ:MRNS

JMP Securities Thinks Marinus’ Stock is Going to Recover

In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Marinus (MRNS – Research Report), with a price target of $23.00. The company’s shares closed last Tuesday at $11.41, close to its 52-week low of

Marinus (MRNS) Receives a Buy from JMP Securities

JMP Securities analyst Jason Butler reiterated a Buy rating on Marinus (MRNS – Research Report) on August 18 and set a price target of $23.00. The company’s shares closed last Friday at $12.35. According to TipRanks.com, Butler is a 4-star

Leerink Partners Sticks to Its Buy Rating for Marinus (MRNS)

In a report issued on August 17, Marc Goodman from Leerink Partners maintained a Buy rating on Marinus (MRNS – Research Report). The company’s shares closed last Wednesday at $11.48. According to TipRanks.com, Goodman is a 2-star analyst with an

Marinus (MRNS) Receives a Buy from Robert W. Baird

In a report issued on August 17, Brian Skorney from Robert W. Baird maintained a Buy rating on Marinus (MRNS – Research Report), with a price target of $32.00. The company’s shares closed last Wednesday at $11.48. According to TipRanks.com,

Robert W. Baird Remains a Buy on Marinus (MRNS)

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Marinus (MRNS – Research Report) on May 17 and set a price target of $32.00. The company’s shares closed last Wednesday at $14.77. According to TipRanks.com, Skorney is a

Analysts Are Bullish on Top Healthcare Stocks: Marinus (MRNS), Moderna (MRNA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Marinus (MRNS – Research Report) and Moderna (MRNA – Research Report) with bullish sentiments. Marinus (MRNS) Ladenburg Thalmann & Co. analyst Michael